Clinical Trial

Clear Cell Chondrosarcoma in Italy

Study acronym: CIRCLE
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Clear cell chondrosarcoma of bone is considered a low-grade malignant tumor in the last WHO classification of soft tissue and bone tumors; however, it is reported that recurrences and metastasis can occur. Considering the uncertain prognosis of this rare tumor, with some cases that historically seems to pursue a bad prognosis, we decided to collect all the Italian cases of clear cell condrosarcoma, in order to better understand its natural history and prognosis.
Trial Details
NCT Number NCT07360964
Lead Sponsor Istituto Ortopedico Rizzoli
Collaborators: Azienda Ospedaliero, Universitaria Pisana, Gaetano Pini CTO, Milano, IRCCS Humanitas Research Hospital, Milano, Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale, Ospedale "Morgagni - Pierantoni" di Forlì, A.O.U. Città della Salute e della Scienza, Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Conditions Chondrosarcoma
Enrollment 77 participants
Start Date 2025-09-10
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-01-22